160 related articles for article (PubMed ID: 11825993)
1. In vitro activities of broad-spectrum cephalosporins against nonmeningeal isolates of Streptococcus pneumoniae: MIC interpretation using NCCLS M100-S12 recommendations.
Sahm DF; Thornsberry C; Mayfield DC; Jones ME; Karlowsky JA
J Clin Microbiol; 2002 Feb; 40(2):669-74. PubMed ID: 11825993
[TBL] [Abstract][Full Text] [Related]
2. Tracking the implementation of NCCLS M100-S12 expanded-spectrum cephalosporin MIC breakpoints for nonmeningeal isolates of Streptococcus pneumoniae by clinical laboratories in the United States during 2002 and 2003.
Master RN; Draghi DC; Jones ME; Thornsberry C; Sahm DF; Karlowsky JA
Ann Clin Microbiol Antimicrob; 2004 Jan; 3():1. PubMed ID: 14713319
[TBL] [Abstract][Full Text] [Related]
3. Impact of modified nonmeningeal Streptococcus pneumoniae interpretive criteria (NCCLS M100-S12) on the susceptibility patterns of five parenteral cephalosporins: report from the SENTRY antimicrobial surveillance program (1997 to 2001).
Jones RN; Mutnick AH; Varnam DJ
J Clin Microbiol; 2002 Nov; 40(11):4332-3. PubMed ID: 12409423
[TBL] [Abstract][Full Text] [Related]
4. Importance of using current NCCLS breakpoints to interpret cefotaxime and ceftriaxone MICs for Streptococcus pneumoniae.
Karlowsky JA; Jones ME
J Antimicrob Chemother; 2003 Feb; 51(2):467-8. PubMed ID: 12562727
[No Abstract] [Full Text] [Related]
5. Influence of penicillin/amoxicillin non-susceptibility on the activity of third-generation cephalosporins against Streptococcus pneumoniae.
Fenoll A; Giménez MJ; Robledo O; Aguilar L; Tarragó D; Granizo JJ; Martín-Herrero JE
Eur J Clin Microbiol Infect Dis; 2008 Jan; 27(1):75-80. PubMed ID: 17943330
[TBL] [Abstract][Full Text] [Related]
6. The effect of cephalosporin resistance on mortality in adult patients with nonmeningeal systemic pneumococcal infections.
Pallares R; Capdevila O; Liñares J; Grau I; Onaga H; Tubau F; Schulze MH; Hohl P; Gudiol F
Am J Med; 2002 Aug; 113(2):120-6. PubMed ID: 12133750
[TBL] [Abstract][Full Text] [Related]
7. Effect of new susceptibility breakpoints on reporting of resistance in Streptococcus pneumoniae--United States, 2003.
Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep; 2004 Feb; 53(7):152-4. PubMed ID: 14985653
[TBL] [Abstract][Full Text] [Related]
8. Clinical isolates of Streptococcus pneumoniae with different susceptibilities to ceftriaxone and cefotaxime.
Karlowsky JA; Jones ME; Draghi DC; Sahm DF
Antimicrob Agents Chemother; 2003 Oct; 47(10):3155-60. PubMed ID: 14506024
[TBL] [Abstract][Full Text] [Related]
9. Predicting susceptibility of Streptococcus pneumoniae to ceftriaxone and cefotaxime by cefuroxime and ceftizoxime disk diffusion testing.
Williams-Bouyer N; Hernandez A; Reisner BS
J Clin Microbiol; 1999 Nov; 37(11):3707-10. PubMed ID: 10523580
[TBL] [Abstract][Full Text] [Related]
10. In vitro killing of penicillin-susceptible, -intermediate, and -resistant strains of Streptococcus pneumoniae by cefotaxime, ceftriaxone, and ceftizoxime: a comparison of bactericidal and inhibitory activity with achievable CSF levels.
Stratton CW; Aldridge KE; Gelfand MS
Diagn Microbiol Infect Dis; 1995; 22(1-2):35-42. PubMed ID: 7587048
[TBL] [Abstract][Full Text] [Related]
11. Antibiotic therapy and acute outcome of meningitis due to Streptococcus pneumoniae considered intermediately susceptible to broad-spectrum cephalosporins.
Tan TQ; Schutze GE; Mason EO; Kaplan SL
Antimicrob Agents Chemother; 1994 May; 38(5):918-23. PubMed ID: 8067771
[TBL] [Abstract][Full Text] [Related]
12. In vitro activities of cefotaxime, ceftriaxone, ceftazidime, cefpirome, and penicillin against Streptococcus pneumoniae isolates.
Barry AL; Brown SD; Novick WJ
Antimicrob Agents Chemother; 1995 Oct; 39(10):2193-6. PubMed ID: 8619565
[TBL] [Abstract][Full Text] [Related]
13. Differences between ceftriaxone and cefotaxime: microbiological inconsistencies.
Gums JG; Boatwright DW; Camblin M; Halstead DC; Jones ME; Sanderson R
Ann Pharmacother; 2008 Jan; 42(1):71-9. PubMed ID: 18094350
[TBL] [Abstract][Full Text] [Related]
14. Relationship of MICs to efficacy of cefotaxime in treatment of Streptococcus pneumoniae infections.
Jacobs RF; Kaplan SL; Schutze GE; Dajani AS; Leggiadro RJ; Rim CS; Puri SK
Antimicrob Agents Chemother; 1996 Apr; 40(4):895-8. PubMed ID: 8849247
[TBL] [Abstract][Full Text] [Related]
15. In vitro evaluation of the antimicrobial activity of ceftaroline against cephalosporin-resistant isolates of Streptococcus pneumoniae.
McGee L; Biek D; Ge Y; Klugman M; du Plessis M; Smith AM; Beall B; Whitney CG; Klugman KP
Antimicrob Agents Chemother; 2009 Feb; 53(2):552-6. PubMed ID: 19015339
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of selected cephalosporins and erythromycin against staphylococci and pneumococci isolated at 38 North American medical centers participating in the SENTRY Antimicrobial Surveillance Program, 1997-1998.
Jones RN; Jenkins SG; Hoban DJ; Pfaller MA; Ramphal R
Diagn Microbiol Infect Dis; 2000 Jun; 37(2):93-8. PubMed ID: 10863103
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity of ceftaroline against multidrug-resistant Staphylococcus aureus and Streptococcus pneumoniae: a review of published studies and the AWARE Surveillance Program (2008-2010).
Farrell DJ; Castanheira M; Mendes RE; Sader HS; Jones RN
Clin Infect Dis; 2012 Sep; 55 Suppl 3():S206-14. PubMed ID: 22903953
[TBL] [Abstract][Full Text] [Related]
18. In vitro susceptibility of Streptococcus pneumoniae strains to nine beta-lactam antibiotics and the killing kinetics of cephalosporins alone and in combination with vancomycin or gentamicin.
Marton A; Major P
Microb Drug Resist; 1996; 2(3):361-9. PubMed ID: 9158796
[TBL] [Abstract][Full Text] [Related]
19. In vitro activity of cefditoren and other antimicrobial agents against 288 Streptococcus pneumoniae and 220 Haemophilus influenzae clinical strains isolated in Zaragoza, Spain.
Seral C; Suárez L; Rubio-Calvo C; Gómez-Lus R; Gimeno M; Coronel P; Durán E; Becerril R; Oca M; Castillo FJ
Diagn Microbiol Infect Dis; 2008 Oct; 62(2):210-5. PubMed ID: 18715733
[TBL] [Abstract][Full Text] [Related]
20. A comparative study of the in-vitro activity of cefepime and other antimicrobial agents against penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae.
Yee YC; Thornsberry C; Brown SD; Bouchillon SK; Marler JK; Rich T
J Antimicrob Chemother; 1993 Nov; 32 Suppl B():13-9. PubMed ID: 8150756
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
